Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient – Kaiser Health News
Kaiser Health News |
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
Kaiser Health News Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the … Patients could end up paying more than $1M for new gene therapy |
